Blood contact type functional material as well as preparation method and application thereof
A technology of functional materials and blood, applied in medical science, surgery, coating, etc., can solve problems such as loss of coating function, coating wear, weak bonding force, etc., and achieve excellent resistance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0021] An embodiment of the present invention provides a method for preparing a blood-contact functional material, which includes the following steps:
[0022] Polyphenol compounds with carboxyl functional groups and polyamine molecules are dissolved in carbodiimide reaction system, and polyamine adhesion molecules modified with polyphenol compounds are constructed through condensation reaction; polyamine modified with polyphenol compounds Adhesion-like molecules are soluble in water and undergo oxidative polymerization under alkaline conditions to form an amino-rich poly(phenol-amine) coating on the substrate; Coating modified substrates for covalent grafting of heparin.
[0023] The inventors found that when the functional material is used as a material for vascular stents, not only does it not have the problem of loss of heparin functional molecules modified at this part due to coating scratches and shedding caused by huge deformation and friction during the implantation pr...
Embodiment 1
[0040] This embodiment provides a blood-contact functional material, including the following steps:
[0041] (1) Dissolve 0.5mg / mL of hydrocaffeic acid and 5mg / mL of polyallylamine (molecular weight is about 10000Da) in 9.76mg / mL of 2-(N-morpholine)ethanesulfonic acid (MES), 1mg / mL of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and 0.24 mg / mL of N-hydroxysuccinamide (NHS) in a solution (pH 5.6), After reacting for 12 hours and dialysis in pure water for 24 hours, polyamine-based adhesion molecules modified by polyphenol compounds (marked as HCAPA) were obtained. Subsequently, the peripheral vascular stent is placed in a Tris (pH value 8.5) buffer solution containing 5 mg / mL of HCAPA, reacted at room temperature for 12 hours, and a layer of surface-rich amine-based coating (marked as PHCAPA).
[0042] (2) Prepare 50mL MES buffer solution (concentration is 10mg / mL), add EDC, NHS and heparin molecule (Hep), the concentration is 0.1mg / mL, 0.24mg / mL, 0.2mg / mL respective...
Embodiment 2
[0044] This embodiment provides a method for preparing blood-contact functional materials, including the following steps:
[0045] (1) Dissolve gallic acid and polylysine (molecular weight is about 1000Da) in 2-(N-morpholine) ethanesulfonic acid, 1-ethyl-3-(3-dimethylaminopropyl) In the acidic solution that carbodiimide and N-hydroxysuccinamide form, control gallic acid, polylysine, 2-(N-morpholine) ethanesulfonic acid, 1-ethyl-3-( The concentrations of 3-dimethylaminopropyl) carbodiimide and N-hydroxysuccinamide were 0.01mg / mL, 0.01mg / mL, 9.5mg / mL, 0.5mg / mL, 0.2mg / mL, and the reaction time for 6 hours. After the reaction is completed, polyphenol-modified polyamine molecules are obtained.
[0046] (2) The peripheral vascular stent is placed in a Tris (pH 7) buffer solution containing 0.1 mg / mL polyphenol-modified polyamine molecules, and reacted at room temperature for 6 hours, that is, a layer of surface is obtained on the surface of the peripheral vascular stent Amine-ric...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com